Loebinger MR - Search Results

1

A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia.

Kos R, Goutaki M, Kobbernagel HE, Rubbo B, Shoemark A, Aliberti S, Altenburg J, Anagnostopoulou P, Athanazio RA, Beydon N, Dell SD, Emiralioglu N, Ferkol TW, Loebinger MR, Lorent N, Maître B, Marthin J, Morgan LC, Nielsen KG, Ringshausen FC, Shteinberg M, Tiddens HAWM, Maitland-Van der Zee AH, Chalmers JD, Lucas JSA, Haarman EG. Kos R, et al. Among authors: loebinger mr. ERJ Open Res. 2024 Jan 8;10(1):00115-2023. doi: 10.1183/23120541.00115-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38196895 Free PMC article.

2

Mesenchymal stem cells as vectors for lung disease.

Loebinger MR, Sage EK, Janes SM. Loebinger MR, et al. Proc Am Thorac Soc. 2008 Aug 15;5(6):711-6. doi: 10.1513/pats.200801-009AW. Proc Am Thorac Soc. 2008. PMID: 18684723 Free PMC article. Review.

3

Community acquired pneumonia: assessment and treatment.

Patterson CM, Loebinger MR. Patterson CM, et al. Among authors: loebinger mr. Clin Med (Lond). 2012 Jun;12(3):283-6. doi: 10.7861/clinmedicine.12-3-283. Clin Med (Lond). 2012. PMID: 22783785 Free PMC article. Review. No abstract available.

4

Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.

Loebinger MR, Eddaoudi A, Davies D, Janes SM. Loebinger MR, et al. Cancer Res. 2009 May 15;69(10):4134-42. doi: 10.1158/0008-5472.CAN-08-4698. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435900 Free PMC article.

5

Therapeutic potential of stem cells in lung disease: progress and pitfalls.

Loebinger MR, Aguilar S, Janes SM. Loebinger MR, et al. Clin Sci (Lond). 2008 Jan;114(2):99-108. doi: 10.1042/CS20070073. Clin Sci (Lond). 2008. PMID: 18062775 Review.

6

Pharmacotherapy for bronchiectasis.

Loebinger MR, Wilson R. Loebinger MR, et al. Expert Opin Pharmacother. 2007 Dec;8(18):3183-93. doi: 10.1517/14656566.8.18.3183. Expert Opin Pharmacother. 2007. PMID: 18035962 Review.

7

Stem cells for lung disease.

Loebinger MR, Janes SM. Loebinger MR, et al. Chest. 2007 Jul;132(1):279-85. doi: 10.1378/chest.06-2751. Chest. 2007. PMID: 17625088 Review.

8

Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung.

Aguilar S, Nye E, Chan J, Loebinger M, Spencer-Dene B, Fisk N, Stamp G, Bonnet D, Janes SM. Aguilar S, et al. Stem Cells. 2007 Jun;25(6):1586-94. doi: 10.1634/stemcells.2006-0762. Epub 2007 Mar 15. Stem Cells. 2007. PMID: 17363552

9

Challenges in the development of new therapies for bronchiectasis.

Chalmers JD, Loebinger M, Aliberti S. Chalmers JD, et al. Expert Opin Pharmacother. 2015 Apr;16(6):833-50. doi: 10.1517/14656566.2015.1019863. Expert Opin Pharmacother. 2015. PMID: 25800083 Review.

10

Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration.

Aliberti S, Masefield S, Polverino E, De Soyza A, Loebinger MR, Menendez R, Ringshausen FC, Vendrell M, Powell P, Chalmers JD; EMBARC Study Group. Aliberti S, et al. Among authors: loebinger mr. Eur Respir J. 2016 Sep;48(3):632-47. doi: 10.1183/13993003.01888-2015. Epub 2016 Jun 10. Eur Respir J. 2016. PMID: 27288031 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page